173 related articles for article (PubMed ID: 27623556)
21. Development of efficient on-bead protein elution process coupled to ultra-high performance liquid chromatography-tandem mass spectrometry to determine immunoglobulin G subclass and glycosylation for discovery of bio-signatures in pancreatic disease.
Shiao JY; Chang YT; Chang MC; Chen MX; Liu LW; Wang XY; Tsai YJ; Kuo TC; Tsai IL
J Chromatogr A; 2020 Jun; 1621():461039. PubMed ID: 32295703
[TBL] [Abstract][Full Text] [Related]
22. Utility of serum IgG, IgG4 and carbonic anhydrase II antibodies in distinguishing autoimmune pancreatitis from pancreatic cancer and chronic pancreatitis.
Talar-Wojnarowska R; Gąsiorowska A; Olakowski M; Dranka-Bojarowska D; Lampe P; Śmigielski J; Kujawiak M; Grzegorczyk J; Małecka-Panas E
Adv Med Sci; 2014 Sep; 59(2):288-92. PubMed ID: 25194335
[TBL] [Abstract][Full Text] [Related]
23. The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing.
Zhou W; Zhang D; Li Z; Jiang H; Li J; Ren R; Gao X; Li J; Wang X; Wang W; Yang Y
J Transl Med; 2021 May; 19(1):215. PubMed ID: 34006295
[TBL] [Abstract][Full Text] [Related]
24. Autoimmune Pancreatitis Type 2: Diagnostic Utility of PD-L1 Immunohistochemistry.
Gupta R; Neyaz A; Chougule A; Akita M; Zen Y; Forcione D; Castillo CF; Ferrone CR; Deshpande V
Am J Surg Pathol; 2019 Jul; 43(7):898-906. PubMed ID: 31135488
[TBL] [Abstract][Full Text] [Related]
25. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma.
Yoon SB; Jeon TY; Moon SH; Lee SM; Kim MH
Eur Radiol; 2022 Oct; 32(10):6691-6701. PubMed ID: 35486167
[TBL] [Abstract][Full Text] [Related]
26. Role of Amylase-α2A Autoantibodies in the Diagnosis of Autoimmune Pancreatitis.
Sánchez Castañón M; Zuliani V; Amodio A; Campagnola P; Granato A; Gabbrielli A; Benini L; López Hoyos M; Frulloni L
Pancreas; 2015 Oct; 44(7):1078-82. PubMed ID: 26335011
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune pancreatitis-related cholecystitis: a morphologically and immunologically distinctive form of lymphoplasmacytic sclerosing cholecystitis.
Wang WL; Farris AB; Lauwers GY; Deshpande V
Histopathology; 2009 Jun; 54(7):829-36. PubMed ID: 19635102
[TBL] [Abstract][Full Text] [Related]
28. The role of apparent diffusion coefficient value in the diagnosis of localized type 1 autoimmune pancreatitis: differentiation from pancreatic ductal adenocarcinoma and evaluation of response to steroids.
Sekito T; Ishii Y; Serikawa M; Tsuboi T; Kawamura R; Tsushima K; Nakamura S; Hirano T; Fukiage A; Mori T; Ikemoto J; Kiyoshita Y; Saeki S; Tamura Y; Miyamoto S; Chayama K
Abdom Radiol (NY); 2021 May; 46(5):2014-2024. PubMed ID: 33386451
[TBL] [Abstract][Full Text] [Related]
29. Identification of commensal flora-associated antigen as a pathogenetic factor of autoimmune pancreatitis.
Yanagisawa N; Haruta I; Shimizu K; Furukawa T; Higuchi T; Shibata N; Shiratori K; Yagi J
Pancreatology; 2014; 14(2):100-6. PubMed ID: 24650962
[TBL] [Abstract][Full Text] [Related]
30. Testing for Anti-PBP Antibody Is Not Useful in Diagnosing Autoimmune Pancreatitis.
Buijs J; Cahen DL; van Heerde MJ; Hansen BE; van Buuren HR; Peppelenbosch MP; Fuhler GM; Bruno MJ
Am J Gastroenterol; 2016 Nov; 111(11):1650-1654. PubMed ID: 27325222
[TBL] [Abstract][Full Text] [Related]
31. Utility of pVHL, maspin, IMP3, S100P and Ki67 in the distinction of autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Hedegaard Jensen G; Mortensen MB; Klöppel G; Nielsen MFB; Nielsen O; Detlefsen S
Pathol Res Pract; 2020 May; 216(5):152925. PubMed ID: 32273198
[TBL] [Abstract][Full Text] [Related]
32. Differentiating focal autoimmune pancreatitis and pancreatic ductal adenocarcinoma: contrast-enhanced MRI with special emphasis on the arterial phase.
Kwon JH; Kim JH; Kim SY; Byun JH; Kim HJ; Lee MG; Lee SS
Eur Radiol; 2019 Nov; 29(11):5763-5771. PubMed ID: 31028441
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process.
Löhr JM; Faissner R; Koczan D; Bewerunge P; Bassi C; Brors B; Eils R; Frulloni L; Funk A; Halangk W; Jesenofsky R; Kaderali L; Kleeff J; Krüger B; Lerch MM; Lösel R; Magnani M; Neumaier M; Nittka S; Sahin-Tóth M; Sänger J; Serafini S; Schnölzer M; Thierse HJ; Wandschneider S; Zamboni G; Klöppel G
Am J Gastroenterol; 2010 Sep; 105(9):2060-71. PubMed ID: 20407433
[TBL] [Abstract][Full Text] [Related]
34. IgG4+ to IgG+ plasma cells ratio of ampulla can help differentiate autoimmune pancreatitis from other "mass forming" pancreatic lesions.
Sepehr A; Mino-Kenudson M; Ogawa F; Brugge WR; Deshpande V; Lauwers GY
Am J Surg Pathol; 2008 Dec; 32(12):1770-9. PubMed ID: 18779730
[TBL] [Abstract][Full Text] [Related]
35. Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Qiu YJ; Zhao GC; Shi SN; Zuo D; Zhang Q; Dong Y; Lou WH; Wang WP
Clin Hemorheol Microcirc; 2022; 81(2):149-161. PubMed ID: 35253737
[TBL] [Abstract][Full Text] [Related]
36. Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis.
Asada M; Nishio A; Uchida K; Kido M; Ueno S; Uza N; Kiriya K; Inoue S; Kitamura H; Ohashi S; Tamaki H; Fukui T; Matsuura M; Kawasaki K; Nishi T; Watanabe N; Nakase H; Chiba T; Okazaki K
Pancreas; 2006 Jul; 33(1):20-6. PubMed ID: 16804408
[TBL] [Abstract][Full Text] [Related]
37. No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassay.
Liberati D; Marzinotto I; Brigatti C; Dugnani E; Pasquale V; Reni M; Balzano G; Falconi M; Piemonti L; Lampasona V
Cancer Biomark; 2018; 22(2):351-357. PubMed ID: 29660901
[TBL] [Abstract][Full Text] [Related]
38. Incidence of the focal type of autoimmune pancreatitis in chronic pancreatitis suspected to be pancreatic carcinoma: experience of a single tertiary cancer center.
Kajiwara M; Gotohda N; Konishi M; Nakagohri T; Takahashi S; Kojima M; Kinoshita T
Scand J Gastroenterol; 2008 Jan; 43(1):110-6. PubMed ID: 18158696
[TBL] [Abstract][Full Text] [Related]
39. Autoantibody signature in human ductal pancreatic adenocarcinoma.
Tomaino B; Cappello P; Capello M; Fredolini C; Ponzetto A; Novarino A; Ciuffreda L; Bertetto O; De Angelis C; Gaia E; Salacone P; Milella M; Nisticò P; Alessio M; Chiarle R; Giuffrida MG; Giovarelli M; Novelli F
J Proteome Res; 2007 Oct; 6(10):4025-31. PubMed ID: 17824682
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic cancer in patients with autoimmune pancreatitis: A scoping review.
Macinga P; Bajer L; Del Chiaro M; Chari ST; Dite P; Frulloni L; Ikeura T; Kamisawa T; Kubota K; Naitoh I; Okazaki K; Pezzilli R; Vujasinovic M; Spicak J; Hucl T; Lӧhr M
Pancreatology; 2021 Aug; 21(5):928-937. PubMed ID: 33775564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
